Skip to main content

Table 1 Relationship between JARID1B protein expression and clinicopathological features in CRC patients

From: JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level

Parameters Total 54a Relative JARID1B protein expressionb P value
Gender    0.53
 Male 36 2.11 ± 0.85  
 Female 18 2.34 ± 0.89  
Age (years)    0.71
 ≤ 60 20 2.14 ± 0.93  
 > 60 34 2.22 ± 0.83  
Tumor size (cm)    0.00**
 < 5 23 1.61 ± 0.80  
 ≥ 5 31 2.62 ± 0.62  
Preoperative CEA level    0.00**
 < 5 ng/mL 40 1.86 ± 0.72  
 ≥ 5 ng/mL 15 3.13 ± 0.41  
Histologic grade    0.98
 well differentiated 42 2.17 ± 0.89  
 poorly differentiated 12 2.26 ± 0.80  
T classification    0.00**
 T1 + T2 17 1.19 ± 0.54  
 T3 + T4 37 2.65 ± 0.53  
TNM stage    0.38
 I 4 1.57 ± 0.55  
 II 14 2.28 ± 1.02  
 III 28 2.18 ± 0.88  
 IV 8 2.37 ± 0.51  
Lymphatic invasion    0.52
 Negative 21 2.12 ± 0.91  
 Positive 33 2.24 ± 0.84  
Distant metastasis    0.88
 Negative 45 2.16 ± 0.92  
 Positive 9 2.33 ± 0.50  
  1. a54 fresh tissue samples from June 2018 to December 2018, bprotein level in Tumor tissues/protein level in Adjacent tissues (mean ± SD),**p ≤ 0.01